REGIMEN COULD BE THE FIRST TO MEET WHO CRITERIA The regimen we are proposing could be the first to meet the WHO criteria below for a pan-TB indication, being fully comprised of new agents unaffected by current resistance. Minimal Optimal Purpose Potential go/no-go decision point. Needed to achieve greater global impact. Indication 1st-line treatment [...]
REDUCING TB TREATMENT TO FOUR MONTHSOur trial, panTB-HM, responds to the Project to Accelerate New Treatments for Tuberculosis (PAN-TB). PAN-TB is a consortium of philanthropists seeking to accelerate the development of novel, shorter Tuberculosis treatments which are simpler to use and have better tolerability. panTB-HM, a phase 2c trial, will test Sutezolid at 2 dose [...]
